scholarly journals Medication Adherence among Type 2 Diabetes Mellitus Patients: A Cross Sectional Study in Rural Karnataka (India)

2021 ◽  
Vol 8 (2) ◽  
pp. 107-118
Author(s):  
Hemant Kumar ◽  
Rufaidha Amara Abdulla ◽  
Heena Lalwani

India currently represents 17% of the world’s diabetes burden, with an estimated 77 million cases in 2019, a figure expected to almost double to 134 million by 2025. Currently, one in every four persons under 25 has adult-onset diabetes, a condition more usually seen in 40–50 year old people. A hospital-based cross-sectional study conducted among diabetes type 2 patients in a rural field practice area of the A.J. Institute of Medical Sciences & Research Centre, Mangalore, Karnataka. Medication adherence and factors associated with non-adherence to medication were determined using self-structured validated questionnaire. A total of 206 patients with type 2 diabetes were recruited. In the present study 49% of the patients were found to be having poor medication adherence, while 50.9% were found to be with good adherence. However, none of the patients showed perfect adherence. A significant association was observed between medication adherence and age of patients, their gender, information about the disease, family support, personal motivation, literacy status and cost of treatment. Keywords: medication adherence, type 2 diabetes mellitus, self-care practices, prevalence

2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Irene A. Kretchy ◽  
Augustina Koduah ◽  
Thelma Ohene-Agyei ◽  
Vincent Boima ◽  
Bernard Appiah

Background. Type 2 diabetes mellitus (T2DM) is a major public health problem associated with distress. T2DM can affect health outcomes and adherence to medications. Little is however known about the association between diabetes distress and medication adherence among patients with T2DM in Ghana. Objective. The objective of the present study is twofold: to estimate distress associated with T2DM and to examine its association with medication adherence. Methods. A hospital-based cross-sectional study was conducted among 188 patients with T2DM recruited from a diabetes specialist outpatient clinic at the Pantang Hospital in Accra, Ghana. Data were obtained using the Problem Areas In Diabetes (PAID) scale and the Medication Adherence Report Scale. Results. The findings showed that about 44.7% of the patients showed high levels of diabetes-related distress. Poor adherence to medications was recorded in 66.5% of the patients. Patients who were highly distressed had 68% lower odds of adhering to their medications compared to those who were not (OR: 0.32, 95% CI: 0.15-0.65). A principal component analysis revealed four areas of T2DM distress which were conceptualized as negative emotions about diabetes, dietary concerns and diabetes care, dissatisfaction with external support, and diabetes management helplessness. Conclusion. Our findings suggest that diabetes distress is a significant determinant of medication adherence behaviour in patients with T2DM. Thus, incorporating routine screening for distress into the standard diabetes care within the Ghanaian health system and having health practitioners adopt holistic approaches to diabetes management will be important context-specific interventions to improve adherence and health outcomes of people living and coping with T2DM.


F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 435
Author(s):  
Ameena Asheq ◽  
Akram Ashames ◽  
Moawia Al-Tabakha ◽  
Nageeb Hassan ◽  
Ammar Jairoun

Background: Patients with chronic diseases often experience difficulty adhering to recommended treatments as instructed by their healthcare professionals. Recently, diabetes has been associated with the severity of the novel coronavirus disease (Covid-19), which raises the importance of improving medication adherence for diabetic patients to enhance the right use of antidiabetics amid the Covid-19 pandemic. Methods: This work assesses medication adherence among type 2 diabetes mellitus patients in the United Arab Emirates (UAE) and identifies the set of key demographic and health factors significantly associated with medication adherence. A descriptive cross-sectional study was conducted on an appropriate sample of type 2 diabetic patients in the UAE, with 180 patients of both genders and various social levels. A validated version of the eight-item Morisky Medication Adherence Scale (MMAS) was used for data collection. Results:  The average MMAS score was 4.88, with 95% confidence intervals (CI) 4.6 and 5.2. 61.67% (n=111), 28.89% (n=52), and 9.44% (n=17) of patients were categorized into low, medium, and high adherent groups, respectively. These findings indicate that a high level of non-compliance to antidiabetic regimens among the population in the UAE. Conclusions: Patients demonstrated low level of compliance to antidiabetic regimens. Therefore, they must receive up-to-date knowledge about the disease and the treatment and enable easy access to their health care providers to enhance medication adherence.


F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 435
Author(s):  
Ameena Asheq ◽  
Akram Ashames ◽  
Moawia Al-Tabakha ◽  
Nageeb Hassan ◽  
Ammar Jairoun

Background: Patients with chronic diseases often experience difficulty adhering to recommended treatments as instructed by their healthcare professionals. Recently, diabetes has been associated with the severity of the novel coronavirus disease (Covid-19), which raises the importance of improving medication adherence for diabetic patients to enhance the right use of antidiabetics amid the Covid-19 pandemic. Methods: This work assesses medication adherence among type 2 diabetes mellitus patients in the United Arab Emirates (UAE) and identifies the set of key demographic and health factors significantly associated with medication adherence. A descriptive cross-sectional study was conducted on an appropriate sample of type 2 diabetic patients in the UAE, with 180 patients of both genders and various social levels. A validated version of the eight-item Morisky Medication Adherence Scale (MMAS) was used for data collection. Results:  The average MMAS score was 4.88, with 95% confidence intervals (CI) 4.6 and 5.2. 61.67% (n=111), 28.89% (n=52), and 9.44% (n=17) of patients were categorized into low, medium, and high adherent groups, respectively. These findings indicate that a high level of non-compliance to antidiabetic regimens among the population in the UAE. Conclusions: Patients demonstrated low level of compliance to antidiabetic regimens. Therefore, they must receive up-to-date knowledge about the disease and the treatment and enable easy access to their health care providers to enhance medication adherence.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2393-PUB
Author(s):  
KENICHIRO TAKAHASHI ◽  
MINORI SHINODA ◽  
RIKA SAKAMOTO ◽  
JUN SUZUKI ◽  
TADASHI YAMAKAWA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document